Rivaroxaban is an anticoagulant that can prevent the formation of blood clots in adults with deep vein thrombosis, and can prevent the occurrence of pulmonary embolism. Rivaroxaban belongs to the anticoagulant drugs, can prevent the formation of thrombus, clinically used in the treatment of adult deep vein thrombosis, can effectively prevent its recurrence, and can prevent the occurrence of pulmonary embolism, rivaroxaban can also be used in the presence of embolic risk factors for non-valvular atrial fibrillation patients treatment, in addition rivaroxaban can be used for the prevention of hip or knee arthroplasty after the patient, can effectively prevent the formation of blood clots. After the use of the drug, there may be some adverse reactions such as bleeding. Obviously active bleeding, patients who are allergic to this product and pregnant women should not use this drug. Whether domestic or imported rivaroxaban, the efficacy is the same, can be replaced, but the specific use of the drug should follow the doctor’s instructions.